Sachin H. Bhagchandani

Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants

D. Irvine, Sachin Bhagchandani, Jeremiah A. Johnson, 2021, Advanced drug delivery reviews.

Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma

I. Ghobrial, Yivan Jiang, Wencong Wang, 2023, Nature Nanotechnology.

Glycan-costumed virus-like particles promote type 1 anti-tumor immunity

A. Shalek, Jeremiah A. Johnson, Robert Hincapie, 2024, bioRxiv.

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

D. Irvine, A. Alexander-Katz, Kaiyuan Ni, 2022, Nature Materials.

Towards an arthritis flare-responsive drug delivery system

Jeffrey M Karp, Michael Valic, Michael S Valic, 2018, Nature Communications.

A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.

J. Karp, J. Isaacs, N. Bhowmick, 2016, Biomaterials.

Trends in Therapeutic Conjugates: Bench to Clinic.

R. Langer, Rameen Shakur, Sachin Bhagchandani, 2020, Bioconjugate chemistry.

ABC triblock bottlebrush copolymer-based injectable hydrogels: design, synthesis, and application to expanding the therapeutic index of cancer immunochemotherapy

Jeremiah A. Johnson, D. Irvine, Wenxu Zhang, 2020, Chemical science.